Liver Metastases: The Role of Magnetic Resonance Imaging
Overview
Authors
Affiliations
The liver is one of the organs most commonly involved in metastatic disease, especially due to its unique vascularization. It's well known that liver metastases represent the most common hepatic malignant tumors. From a practical point of view, it's of utmost importance to evaluate the presence of liver metastases when staging oncologic patients, to select the best treatment possible, and finally to predict the overall prognosis. In the past few years, imaging techniques have gained a central role in identifying liver metastases, thanks to ultrasonography, contrast-enhanced computed tomography (CT), and magnetic resonance imaging (MRI). All these techniques, especially CT and MRI, can be considered the non-invasive reference standard techniques for the assessment of liver involvement by metastases. On the other hand, the liver can be affected by different focal lesions, sometimes benign, and sometimes malignant. On these bases, radiologists should face the differential diagnosis between benign and secondary lesions to correctly allocate patients to the best management. Considering the above-mentioned principles, it's extremely important to underline and refresh the broad spectrum of liver metastases features that can occur in everyday clinical practice. This review aims to summarize the most common imaging features of liver metastases, with a special focus on typical and atypical appearance, by using MRI.
Scarciglia A, Papi C, Romiti C, Leone A, Di Gregorio E, Ferrauto G Glob Chall. 2025; 9(3):2400269.
PMID: 40071223 PMC: 11891575. DOI: 10.1002/gch2.202400269.
Ghenciu L, Grigoras M, Rosu L, Bolintineanu S, Sima L, Cretu O Biomedicines. 2025; 13(1.
PMID: 39857748 PMC: 11759174. DOI: 10.3390/biomedicines13010164.
Barajas Ordonez F, Gottschling S, Eger K, Borggrefe J, Jechorek D, Surov A Insights Imaging. 2024; 15(1):294.
PMID: 39636546 PMC: 11621246. DOI: 10.1186/s13244-024-01866-7.
Imaging and Metabolic Diagnostic Methods in the Stage Assessment of Rectal Cancer.
Maksim R, Buczynska A, Sidorkiewicz I, Kretowski A, Sierko E Cancers (Basel). 2024; 16(14).
PMID: 39061192 PMC: 11275086. DOI: 10.3390/cancers16142553.
Wijnen N, Bruijnen R, Thelissen A, W A M de Jong H, van Leeuwaarde R, Hagendoorn J Cancers (Basel). 2024; 16(13).
PMID: 39001471 PMC: 11240348. DOI: 10.3390/cancers16132409.